| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797712 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 09/28/2004 | US6797711 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 09/28/2004 | US6797710 Cardiovascular disorders; serine protease inhibitor; administering by mouth; bioavailability |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/28/2004 | US6797705 Rhamnan sulphate composition for treatment of endothelial dysfunction |
| 09/28/2004 | US6797702 Methods and compositions comprising DNA damaging agents and P53 |
| 09/28/2004 | US6797701 Topical mixture; containing avermectin, milbemycin |
| 09/28/2004 | US6797699 Exemplified by n'-l-arginylspermidine |
| 09/28/2004 | US6797696 Contacting a bodily fluid with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide to form a complex and detecting the complex; treating malignant neoplasms by inhibiting haah. |
| 09/28/2004 | US6797694 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction |
| 09/28/2004 | US6797693 Methods using PTPase inhibitors and insulin |
| 09/28/2004 | US6797692 Use of glutamate antagonists for the treatment of cancer |
| 09/28/2004 | US6797511 Basis of its ability to bind to presenilin 1; for treatment of alzheimer's disease |
| 09/28/2004 | US6797504 For prevention and treatment of cancer, tumors, metastasis; drug screening |
| 09/28/2004 | US6797502 Polypeptide for use in the treatment of hypertriglyceridemia, atherosclerosis and eating disorders |
| 09/28/2004 | US6797291 Comprises protective lipid coating (hydrogenated oils) for choline chloride or lysine hydrochloride; ruminant feeds |
| 09/28/2004 | US6797290 Oral administration of chitosan and glycomacropeptide (gmp), wherein the chitosan and gmp are in other than a cationic gum or polysaccharide/protein complex; cholecystokinin (cck) stimulant; anticholesterol, -lipemic agents |
| 09/28/2004 | US6797289 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 09/28/2004 | US6797284 Plant extracts and amino acids, that can be used to reduce tobacco smoke addiction |
| 09/28/2004 | US6797283 Gastric retention dosage form having multiple layers |
| 09/28/2004 | US6797282 Combination progestin oral contraceptive regimen |
| 09/28/2004 | US6797281 Esters of I-carnitine or alkanoyl I-carnitines |
| 09/28/2004 | US6797268 Pharmaceutical composition useful in the treatment of peptic ulcers |
| 09/28/2004 | US6797266 Probiotic composition containing Lactobacillus casei strain ATCC PTA-3945 |
| 09/28/2004 | US6797260 Bleeding control and healing aid compositions and methods of use |
| 09/28/2004 | US6797259 Delivery of muscle relaxants through an inhalation route |
| 09/28/2004 | US6797258 Compositions and methods for the pulmonary delivery of aerosolized macromolecules |
| 09/28/2004 | US6796975 Container for linezolid intravenous solution |
| 09/28/2004 | US6796966 Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal |
| 09/28/2004 | US6796429 Transdermal/transmucosal patch packaging |
| 09/28/2004 | CA2424183A1 Colonic cleansing composition and method |
| 09/28/2004 | CA2424003A1 Anti-microbial topical composition comprising alcohol and chlorhexidine salt |
| 09/28/2004 | CA2301354C Low temperature expression cdnas encoding fructan synthesizing enzymes and method of isolating the same |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/28/2004 | CA2292359C Novel azalides and methods of making same |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/28/2004 | CA2191088C Copolymer-1 improvements in compositions of copolymers |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/28/2004 | CA2128312C Use of n-(pyridinyl)-1h-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders |
| 09/28/2004 | CA2109028C Stabilized sorbic acid or salt thereof |
| 09/23/2004 | WO2004081050A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004081037A1 Inhibitors of extracellular hsp90 |
| 09/23/2004 | WO2004081013A1 Protein kinase inhibitors |
| 09/23/2004 | WO2004081012A1 Antitumor effect potentiator and antitumor agent |
| 09/23/2004 | WO2004081008A1 Novel fused triazolones and the uses thereof |
| 09/23/2004 | WO2004081007A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 09/23/2004 | WO2004081006A1 Weak base salts |
| 09/23/2004 | WO2004080999A1 Pyrazole compounds useful in the treatment of inflammation |
| 09/23/2004 | WO2004080998A1 Imidazol-4-yl-ethynyl-pyridine derivatives |
| 09/23/2004 | WO2004080990A1 C-glycoside derivatives and salts thereof |
| 09/23/2004 | WO2004080982A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 09/23/2004 | WO2004080980A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/23/2004 | WO2004080976A1 Phthalazinone derivatives |
| 09/23/2004 | WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | WO2004080965A1 Neuropeptide ff receptor antagonist |
| 09/23/2004 | WO2004080964A1 Indole derivatives useful for the treatment of diseases |
| 09/23/2004 | WO2004080959A2 Process for the preparation of dexmethylphenidate hydrochloride |
| 09/23/2004 | WO2004080956A1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt |
| 09/23/2004 | WO2004080954A1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate form ii crystalline salt |
| 09/23/2004 | WO2004080953A1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine salicylate monohydrate crystalline salt |
| 09/23/2004 | WO2004080951A2 Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 09/23/2004 | WO2004080950A1 Substituted aniline derivatives |
| 09/23/2004 | WO2004080943A1 Cinnamyl alcohol derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | WO2004080933A2 Isolation of lutein from alfalfa |
| 09/23/2004 | WO2004080586A1 Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 09/23/2004 | WO2004080583A2 PROCESS FOR THE PREPARATION OF threo-METHYLPHENIDATE HYDROCHLORIDE |
| 09/23/2004 | WO2004080502A1 Antiadhesive material |
| 09/23/2004 | WO2004080489A1 Treatment of macular degeneration |
| 09/23/2004 | WO2004080488A2 Combined preparations of acetyl salicylic acid with an hmg-coa reductase inhibitor |
| 09/23/2004 | WO2004080487A1 Preventive or remedy for teeth grinding |
| 09/23/2004 | WO2004080486A1 Tumorigenesis inhibitor |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080484A1 Adipocyte differentiation inhibitor |
| 09/23/2004 | WO2004080482A2 Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure |
| 09/23/2004 | WO2004080479A1 Gonadal function improving agents |
| 09/23/2004 | WO2004080474A1 Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising prenyl flavonoids |
| 09/23/2004 | WO2004080470A1 Preventive/remedy for obesity |
| 09/23/2004 | WO2004080469A1 Supplemental food for recovery from hypoglycemic symptoms |
| 09/23/2004 | WO2004080467A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds |
| 09/23/2004 | WO2004080465A1 Method of treating cancer with quinolone carboxylic acid derivatives |
| 09/23/2004 | WO2004080464A1 Use of isoquinoline derivatives for treating cancer and map kinase related diseases |
| 09/23/2004 | WO2004080461A2 Stable pharmaceutical compositions of desloratadine |
| 09/23/2004 | WO2004080459A1 Method for treating mild cognitive impairment and for preventing or delaying alzheimer’s disease |
| 09/23/2004 | WO2004080457A1 Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/23/2004 | WO2004080456A1 Pharmaceutical composition for intracellular acidification with cis-urocanic |
| 09/23/2004 | WO2004080455A1 Antibacterial agent and anticancer agent |
| 09/23/2004 | WO2004080454A1 Composition comprising 5-hydroxytryptophan for reducing or alleviating the effects of nicotine withdrawal and use thereof |
| 09/23/2004 | WO2004080453A1 Antihepatitis c virus agent and anti-hiv agent |
| 09/23/2004 | WO2004080451A1 Pharmaceutical composition comprising 5-methyl-2-2’-(chloro-6’-fluoroanilino) phe nylacetic acid |
| 09/23/2004 | WO2004080450A2 Combined use of a fibrate and orlistat for the treatment of obesity |
| 09/23/2004 | WO2004080449A1 Ultraviolet-induced active oxygen inhibitor |
| 09/23/2004 | WO2004080448A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases |
| 09/23/2004 | WO2004080447A1 Titration dosing regimen for controlled release tramadol |
| 09/23/2004 | WO2004080446A1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine |
| 09/23/2004 | WO2004080445A1 Methods and compositions for the treatment of cancer |
| 09/23/2004 | WO2004080444A2 Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using cav2.2 subunit calcium channel modulators |
| 09/23/2004 | WO2004080443A1 Treatment and/or prevention of non-viral epithelial damage |
| 09/23/2004 | WO2004080442A1 Extended transdermal contraceptive regimens |